Sanjay Mehta
Expertise in
1
conditions

Dr. Sanjay Mehta

Infectious Disease
UC San Diego Student Health SVC Pharmacy
9500 Gilman Dr, 
La Jolla, CA 
Expertise in
1
conditions
UC San Diego Student Health SVC Pharmacy
9500 Gilman Dr, 
La Jolla, CA 

Overview

Sanjay Mehta is an Infectious Disease provider practicing medicine in La Jolla, California.

Dr. Mehta is highly rated in 1 condition, according to our data. His clinical expertise encompasses HIV/AIDS, Arachnoiditis, Sepsis, and Severe Acute Respiratory Syndrome (SARS).

He is actively involved in clinical research, co-authoring 185 peer reviewed articles and participating in 8 clinical trials.

Specialties

Infectious Disease

Licenses

Internal Medicine in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

UC San Diego Student Health SVC Pharmacy
9500 Gilman Dr, La Jolla, CA 92093

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
Enrollment Status: Terminated
Publish Date: January 31, 2025
Intervention Type: Biological
Study Drug: Autologous EPCs transfected with human eNOS
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

185 Total Publications

Successful Control of Refractory Coccidioides Meningitis With MAT2203.
Successful Control of Refractory Coccidioides Meningitis With MAT2203.
Journal: Open forum infectious diseases
Published: November 25, 2025
Similar Doctors
Expertise in
9
conditions
Dr. Edward Cachay
Infectious Disease
Expertise in
9
conditions
Dr. Edward Cachay
Infectious Disease
Referral may be required

UC San Diego

200 W Arbor Dr, 
San Diego, CA 
 (86.6 miles away)
619-543-3995
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Edward Cachay is an Infectious Disease provider practicing medicine in San Diego, California. Dr. Cachay is highly rated in 9 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and Myelitis.

Expertise in
4
conditions
Dr. Adriana Tremoulet
Infectious Disease
Expertise in
4
conditions
Dr. Adriana Tremoulet
Infectious Disease
Referral may be required

Rady Children's Hospital San Diego

3020 Childrens Way, 
San Diego, CA 
 (84.3 miles away)
858-966-7785
Languages Spoken:
English
See accepted insurances

Adriana Tremoulet is an Infectious Disease provider practicing medicine in San Diego, California. Dr. Tremoulet is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Pediatric Myocarditis, and Severe Acute Respiratory Syndrome (SARS).

Expertise in
7
conditions
Dr. George Sakoulas
Infectious Disease
Expertise in
7
conditions
Dr. George Sakoulas
Infectious Disease
Referral may be required

Sharp Rees-Stealy Medical Group-Genesee

2020 Genesee Ave, 
San Diego, CA 
 (84.6 miles away)
858-499-2600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

George Sakoulas is an Infectious Disease provider practicing medicine in San Diego, California. Dr. Sakoulas is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Endocarditis, and Osteomyelitis.

Frequently Asked Questions about Dr. Sanjay Mehta

How do I make an appointment with Dr. Sanjay Mehta?

You can book an appointment with Dr. Sanjay Mehta by calling their office at 858-822-0333. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sanjay Mehta a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sanjay Mehta is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sanjay Mehta specialize in?

While Dr. Sanjay Mehta is a Infectious Disease, they have specific expertise in HIV/AIDS, Arachnoiditis, and Sepsis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Sanjay Mehta participate in research or clinical trials?

Yes. Dr. Sanjay Mehta has published 185 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Sanjay Mehta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sanjay Mehta accept my insurance?

Dr. Sanjay Mehta accepts most major insurance plans, including Managed Medicaid and Medicaid. We recommend calling the office directly at 858-822-0333 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mehta's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile